Spectral Diagnostics (DIAGF) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spectral Diagnostics (DIAGF)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Netnut7 who wrote ()	12/27/1999 11:28:00 AM
From: Dan Dolan	of 4

Hello, knock,knock, anybody there? There's an article in the November 1999 issue of the Association of OR Nurses (AORN) Journal on Biochemical Markers in Myocardial Injury (pp 840-854). There is an AORN website aorn.org but I don't think these articles are posted there. The author points out that testing for cardiac troponin I (cTnI) is highly specific in detecting damaged myocardial tissues. Other tests detect damage to other muscle tissues in addition to cardiac tissue, so they are not as specific to detecting MIs as this troponin test is. The article does not refer to Spectral Diagnostics per se, but there is this quote in the conclusion: "...rapid bedside assays are available to measure troponins. Nurses may be responsible for performing these assays..." Laissez le bon temps roulez! D.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next